Hudson Bay Capital Management
BIOT

Hudson Bay Capital Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Hudson Bay Capital Management’s Portfolio BIOT Stock Details BIOT Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$12.7M Hold
2022
Q3 		$12.5M Hold
2022
Q2 		$12.5M Buy
2022
Q1 		$5.02M Buy
2021
Q4 		$4.84M Buy
2021
Q3 		$3.8M Hold
2021
Q2 		$3.77M Buy
2021
Q1 		$1.94M Buy